Comparison of early tumor shrinkage between oxaliplatin plus S-1 and cisplatin plus S-1 in first-line chemotherapy with advanced gastric cancer.

被引:0
|
作者
Osumi, Hiroki [1 ]
Takahari, Daisuke [1 ]
Shinozaki, Eiji [1 ]
Chin, Keisho [1 ]
Ogura, Mariko [1 ]
Nakayama, Izuma [1 ]
Matsushima, Tomohiro [1 ]
Wakatsuki, Takeru [1 ]
Ichimura, Takashi [1 ]
Suenaga, Mitsukuni [1 ]
Yamaguchi, Kensei [1 ]
机构
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan
关键词
D O I
10.1200/JCO.2017.35.4_suppl.75
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
75
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer
    Kohei Shitara
    Akira Sawaki
    Keitaro Matsuo
    Chihiro Kondo
    Daisuke Takahari
    Takashi Ura
    Masahiro Tajika
    Yasumasa Niwa
    Kei Muro
    International Journal of Clinical Oncology, 2013, 18 : 539 - 546
  • [32] A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer
    Shitara, Kohei
    Sawaki, Akira
    Matsuo, Keitaro
    Kondo, Chihiro
    Takahari, Daisuke
    Ura, Takashi
    Tajika, Masahiro
    Niwa, Yasumasa
    Muro, Kei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 539 - 546
  • [33] S-1 plus oxaliplatin vs. S-1 as first-line treatment in patients with previously untreated advanced gastric cancer: a randomized phase II study
    Lu, Yiming
    Liu, Zanchao
    Zhang, Jun
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (03) : 159 - 164
  • [34] S-1/docetaxel compared with the other standard S-1 based regimens as a first-line chemotherapy for patients with advanced gastric cancer.
    Kusumoto, Tetsuya
    Ando, Koji
    Ida, Satoshi
    Kimura, Yasue
    Saeki, Hiroshi
    Oki, Eiji
    Morita, Masaru
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial
    Hironaka, Shuichi
    Sugimoto, Naotoshi
    Yamaguchi, Kensei
    Moriwaki, Toshikazu
    Komatsu, Yoshito
    Nishina, Tomohiro
    Tsuji, Akihito
    Nakajima, Takako Eguchi
    Gotoh, Masahiro
    Machida, Nozomu
    Bando, Hideaki
    Esaki, Taito
    Emi, Yasunori
    Sekikawa, Takashi
    Matsumoto, Shigemi
    Takeuchi, Masahiro
    Boku, Narikazu
    Baba, Hideo
    Hyodo, Ichinosuke
    LANCET ONCOLOGY, 2016, 17 (01): : 99 - 108
  • [36] A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)
    Nishikawa, Kazuhiro
    Tsuburaya, Akira
    Yoshikawa, Takaki
    Kobayashi, Michiya
    Kawada, Junji
    Fukushima, Ryoji
    Matsui, Takanori
    Tanabe, Kazuaki
    Yamaguchi, Kazuya
    Yoshino, Shigefumi
    Takahashi, Masazumi
    Hirabayashi, Naoki
    Sato, Seiji
    Nemoto, Hiroshi
    Rino, Yasushi
    Nakajima, Junta
    Aoyama, Toru
    Miyagi, Yohei
    Oriuchi, Noboru
    Yamaguchi, Kensei
    Miyashita, Yumi
    Morita, Satoshi
    Sakamoto, Junichi
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 220 - 228
  • [37] Adjuvant chemotherapy for chemotherapy-naive advanced gastric cancer patients with oxaliplatin plus tegafur versus oxaliplatin plus S-1
    Shu, Zhenbo
    Ding, Dayong
    Li, Yongchao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (06): : 9322 - 9329
  • [38] Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Koizumi, Wasaburo
    Tanabe, Satoshi
    Azuma, Mizutomo
    Ishido, Kenji
    Nishimura, Ken
    Sasaki, Tohru
    Nakatani, Kento
    Higuchi, Katsuhiko
    Nakayama, Norisuke
    Katada, Chikatoshi
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (01) : 162 - 170
  • [39] Comparison of S-1 and cisplatin combination versus S-1 adjuvant chemotherapy for advanced gastric cancer
    Kim, Hyo Song
    Jeung, Hei-Cheul
    Jung, Minkyu
    Kim, Hye Ryun
    Ahn, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Chung, Hyun Cheol
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer
    Takahiro Tsushima
    Shuichi Hironaka
    Narikazu Boku
    Nozomu Machida
    Kentaro Yamazaki
    Hirofumi Yasui
    Akira Fukutomi
    Akiko Todaka
    Hiroya Taniguchi
    Yusuke Onozawa
    Keisei Taku
    International Journal of Clinical Oncology, 2013, 18 : 10 - 16